Antiretroviral Therapy Perspective

 
 
  • Contemplating Retirement During COVID-19 Dr Andrew Wilner navigates the tension between his commitment as a physician and the safety of he and his family.
  • HIV and AIDS: Overview Video   Review key aspects of HIV and AIDS —including transmission, disease progression, and prevention and treatment—with this quick overview video.
  • Vanquishing Hepatitis C: A Remarkable Success Story A look back at one of the singular achievements in medical research of the past 25 years, and what improvements are still to come.
  • ANAC 2020 Read clinically focused news coverage of key developments from ANAC 2020
  • USCHA 2020 Read clinically focused news coverage of key developments from USCA 2020
  • HIV Glasgow 2020 Read clinically focused news coverage of key developments from HIV Glasgow 2020
  • Confronting the HIV Epidemic: Taking Down Silos   Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic.
  • Growing Old With HIV: Beyond Just Surviving The aging of the population with HIV is a medical achievement to celebrate, but with this success comes a new conundrum.
  • Confronting the HIV Epidemic: There's an App for That   UNC physicians and scientists use mobile app technology and gamification strategy to engage at-risk and HIV-positive young men in prevention and management of HIV.
  • Drugs to Avoid in Patients on DOACs DOACs overall have substantially fewer drug-drug interactions than warfarin, but there are still a few to watch out for.
  • AIDS 2020 Read clinically focused news coverage of key developments from IAS 2020
  • Long-acting Injectable Cabotegravir for PrEP Is Promising   Dr Paul Sax discusses the interim results from a study on the use of the long-acting injectable cabotegravir for pre-exposure prophylaxis in cisgender men and transgender women who have sex with men.
  • The Promise of Remdesivir for COVID-19 Treatment   WebMD Chief Medical Officer John Whyte talks with Dr Stuart Cohen about remdesivir for the possible treatment of COVID-19 infection, and when we might expect to see the development of a vaccine.
  • Confronting the HIV Epidemic   Infectious disease experts from UNC Chapel Hill have developed innovative methods to engage young minority men, the fastest-growing HIV-positive population, in the prevention and treatment of HIV.
  • COVID-19 in People With HIV: Commonly Asked Questions   Dr Paul Sax gives answers to some of the most commonly asked questions he has received from patients with HIV.
  • Low-Level Viremia in HIV: When Should We Worry?   Is all low-level viremia in HIV the same, and does it lead to virologic failure? Dr Sax comments on a new study.
  • CROI 2020 Read clinically focused news coverage of key developments from CROI 2020
  • Infectious Diseases in 2020: 5 Areas of Concern   Dr Paul Auwaerter discusses advances made in infectious diseases in 2019 and looks ahead at concerns for the new year.
  • Time to Rethink Renal Dosing of Lamivudine?   Dose reductions of lamivudine may not be necessary for all patients with mild to moderate renal impairment, says Dr Paul Sax.
  • ANAC 2019 Read clinically focused news coverage of key developments from ANAC 2019